[1]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30.
https://doi.org/10.3322/caac.21442
|
[2]
|
孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11.
|
[3]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[4]
|
Sauer, R., Becker, H., Hohenberger, W., et al. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. The New England Journal of Medicine, 351, 1731-1740. https://doi.org/10.1056/NEJMoa040694
|
[5]
|
Bosset, J.-F., Collette, L., Calais, G., et al. (2006) Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. The New England Journal of Medicine, 355, 1114-1123. https://doi.org/10.1056/NEJMoa060829
|
[6]
|
Sebag-Montefiore, D., Stephens, R.J., Steele, R., et al. (2009) Pre-operative Radiotherapy versus Selective Postoperative Chemoradiotherapy in Patients with Rectal Cancer (MRC CR07 and NCIC-CTG C016): A Multicentre, Randomised Trial. Lancet, 373, 811-820. https://doi.org/10.1016/S0140-6736(09)60484-0
|
[7]
|
Glynne-Jones, R., Wyrwicz, L., Tiret, E., et al. (2018) Cor-rections to “Rectal Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up”. Annals of On-cology, 29, Article No. IV263.
https://doi.org/10.1093/annonc/mdy161
|
[8]
|
Couwenberg, A.M., Burbach, J.P.M., Van Grevenstein, W.M.U., et al. (2018) Effect of Neoadjuvant Therapy and Rectal Surgery on Health-Related Quality of Life in Patients with Rectal Cancer during the First 2 Years after Diagnosis. Clinical Colorectal Cancer, 17, e499-e512. https://doi.org/10.1016/j.clcc.2018.03.009
|
[9]
|
Roh, M.S., Colangelo, L.H., O’Connell, M.J., Yothers, G., Deutsch, M., Allegra, C.J., Kahlenberg, M.S., Baez-Diaz, L., Ursiny, C.S., Petrelli, N.J. and Wolmark, N. (2009) Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients with Carcinoma of the Rectum: NSABP R-03. Jour-nal of Clinical Oncology, 27, 5124-5130.
https://doi.org/10.1200/JCO.2009.22.0467
|
[10]
|
Allegra, C.J., Yothers, G., O’Connell, M.J., Beart, R.W., Wozniak, T.F., Pitot, H.C., Shields, A.F., Landry, J.C., Ryan, D.P., Arora, A., Evans, L.S., Bahary, N., Soori, G., Eakle, J.F., Robertson, J.M., Moore Jr., D.F., Mullane, M.R., Marchello, B.T., Ward, P.J., Sharif, S., Roh, M.S. and Wolmark, N. (2015) Neoadjuvant 5-FU or Capecitabine plus Radiation with or without Oxaliplatin in Rectal Cancer Patients:A Phase III Randomized Clinical Trial. JNCI: Journal of the National Cancer Institute, 107, Article No. djv248. https://doi.org/10.1093/jnci/djv248
|
[11]
|
Bujko, K., Nowacki, M.P., Kępka, L., Olędzki, J., Bębenek, M. and Kryj, M. (2005) Postoperative Complications in Patients Irradiated Pre-Operatively for Rectal Cancer: Report of a Randomised Trial Comparing Short-Term Radiotherapy vs Chemoradiation. Colorectal Disease, 7, 410-416. https://doi.org/10.1111/j.1463-1318.2005.00796.x
|
[12]
|
Radu, C., Berglund, A., Pahlman, L. and Glimelius, B. (2008) Short-Course Preoperative Radiotherapy with Delayed Surgery in Rectal Cancer—A Retrospective Study. Radio-therapy and Oncology, 87, 343-349.
https://doi.org/10.1016/j.radonc.2007.11.025
|
[13]
|
Latkauskas, T., Pauzas, H., Kairevice, L., Petrauskas, A., Saladzinskas, Z., Janciauskiene, R., Gudaityte, J., Lizdenis, P., Svagzdys, S., Tamelis, A. and Pavalkis, D. (2016) Pre-operative Conventional Chemoradiotherapy versus Short-Course Radiotherapy with Delayed Surgery for Rectal Cancer: Results of a Randomized Controlled Trial. BMC Cancer, 16, Article No. 927. https://doi.org/10.1186/s12885-016-2959-9
|
[14]
|
Yu, Y., Li, Y., Xu, C., Zhang, Z. and Zhang, X. (2019) Compar-ison of Long Course and Short Course Preoperative Radiotherapy in the Treatment of Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Revista Espanola de Enfermedades Digestivas, 111, 17-27. https://doi.org/10.17235/reed.2018.5674/2018
|
[15]
|
Simillis, C., Khatri, A., Dai, N., Afxentiou, T., Jephcott, C., Smith, S., Jadon, R., Papamichael, D., Khan, J., Powar, M.P., Fearnhead, N.S., Wheeler, J. and Davies, J. (2023) A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials Comparing Neoadjuvant Treatment Strategies for Stage II and III Rectal Cancer. Critical Reviews in Oncology/Hematology, 183, Article ID: 103927. https://doi.org/10.1016/j.critrevonc.2023.103927
|
[16]
|
Alawawdeh, A., Krishnan, T., Roy, A., et al. (2021) Curative Therapy for Rectal Cancer. Expert Review of Anticancer Therapy, 21, 193-203. https://doi.org/10.1080/14737140.2021.1845145
|
[17]
|
Glynne-Jones, R., Grainger, J., Harrison, M., Ostler, P. and Makris, A. (2006) Neoadjuvant Chemotherapy Prior to Preoperative Chemoradiation or Radiation in Rectal Cancer: Should We Be More Cautious? British Journal of Cancer, 94, 363-371. https://doi.org/10.1038/sj.bjc.6602960
|
[18]
|
Chua, Y.J., Barbachano, Y., Cunningham, D., et al. (2010) Neoadju-vant Capecitabine and Oxaliplatin Before Chemoradiotherapy and Total Mesorectal Excision in MRI-Defined Poor-Risk Rectal Cancer: A Phase 2 Trial. The Lancet Oncology, 11, 241-248. https://doi.org/10.1016/S1470-2045(09)70381-X
|
[19]
|
Gao, Y.-H., Lin, J.-Z., An, X., et al. (2014) Neoadjuvant Sandwich Treatment with Oxaliplatin and Capecitabine Administered Prior to, Concurrently with, and Following Radia-tion Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 Trial. International Journal of Radiation On-cology, Biology, Physics, 90, 1153-1160.
https://doi.org/10.1016/j.ijrobp.2014.07.021
|
[20]
|
Azin, A., Khorasani, M. and Quereshy, F.A. (2019) Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: The Surgeon’s Perspective. Journal of Clinical Pathology, 72, 133-134. https://doi.org/10.1136/jclinpath-2018-205595
|
[21]
|
Goodman, K.A. (2018) Total Neoadjuvant Therapy for Rectal Cancer. Cancer/Radiothérapie, 22, 459-465.
https://doi.org/10.1016/j.canrad.2018.01.004
|
[22]
|
Kim, H.S. and Kim, N.K. (2020) Challenges and Shifting Treat-ment Strategies in the Surgical Treatment of Locally Advanced Rectal Cancer. Annals of Gastroenterological Surgery, 4, 379-385. https://doi.org/10.1002/ags3.12349
|
[23]
|
Gollins, S. and Sebag-Montefiore, D. (2016) Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer. Clinical Oncology, 28, 146-151. https://doi.org/10.1016/j.clon.2015.11.003
|
[24]
|
Cercek, A., Roxburgh, C.S.D., Strombom, P., et al. (2018) Adop-tion of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncology, 4, e180071. https://doi.org/10.1001/jamaoncol.2018.0071
|
[25]
|
Garcia-Aguilar, J., Patil, S., Kim, J., et al. (2020) Preliminary Results of the Organ Preservation of Rectal Adenocarcinoma (Opra) Trial. Journal of Clinical Oncology, 38, Article No. 4008.
https://doi.org/10.1200/JCO.2020.38.15_suppl.4008
|
[26]
|
Xiao, W. (2019) TNT versus Conventional CRT to In-crease the Sphincter Preservation Rate for Distal LARC (TESS).
https://www.clinicaltrials.gov/ct2/show/NCT03840239
|
[27]
|
Liu, S., Jiang, T., Xiao, L., Yang, S., Liu, Q., Gao, Y., Chen, G. and Xiao, W. (2021) Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. The Oncologist, 26, e1555-e1566. https://doi.org/10.1002/onco.13824
|
[28]
|
Ngan, S.Y., Burmeister, B., Fisher, R.J., et al. (2012) Randomized Trial of Short-Course Radiotherapy versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients with T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. Journal of Clinical Oncology, 30, 3827-3833.
https://doi.org/10.1200/JCO.2012.42.9597
|
[29]
|
Zhou, Z.-R., Liu, S.-X., Zhang, T.-S., et al. (2014) Short-Course Preoperative Radiotherapy with Immediate Surgery versus Long-Course Chemoradiation with Delayed Surgery in the Treatment of Rectal Cancer: A Systematic Review and Meta-Analysis. Surgical Oncology, 23, 211-221. https://doi.org/10.1016/j.suronc.2014.10.003
|
[30]
|
Glimelius, B. (2017) On a Prolonged Interval between Rectal Cancer (Chemo)Radiotherapy and Surgery. Upsala Journal of Medical Sciences, 122, 1-10. https://doi.org/10.1080/03009734.2016.1274806
|
[31]
|
de Campos-Lobato, L.F., Geisler, D.P., da Luz Moreira, A., Stocchi, L., Dietz, D. and Kalady, M.F. (2011) Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval between Chemoradiation and Surgery. Journal of Gastrointestinal Surgery, 15, 444-450. https://doi.org/10.1007/s11605-010-1197-8
|
[32]
|
Zorcolo, L., Rosman, A.S., Restivo, A., Pisano, M., Nigri, G.R., Fancellu, A., et al. (2012) Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis. Annals of Surgical Oncology, 19, 2822-2832. https://doi.org/10.1245/s10434-011-2209-y
|
[33]
|
Francois, Y., Nemoz, C.J., Baulieux, J., et al. (1999) Influence of the Interval between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial. Journal of Clinical Oncology, 17, 2396-2402. 1 https://doi.org/10.1200/JCO.1999.17.8.2396
|
[34]
|
Akgun, E., Caliskan, C., Bozbiyik, O., Yoldas, T., Sezak, M., Ozkok, S., Kose, T., Karabulut, B., Harman, M. and Ozutemiz, O. (2018) Randomized Clinical Trial of Short or Long Interval between Neoadjuvant Chemoradiotherapy and Surgery for Rectal Cancer. British Journal of Surgery, 105, 1417-1425. https://doi.org/10.1002/bjs.10984
|
[35]
|
Terzi, C., Bingul, M., Arslan, N.C., Ozturk, E., Canda, A.E., Isik, O., Yilmazlar, T., Obuz, F., Birkay Gorken, I., Kurt, M., Unlu, M., Ugras, N., Kanat, O. and Oztop, I. (2020) Ran-domized Controlled Trial of 8 Weeks’ vs 12 Weeks’ Interval between Neoadjuvant Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer. Colorectal Disease, 22, 279-288. https://doi.org/10.1111/codi.14867
|
[36]
|
Wu, H., Fang, C., Huang, L., Fan, C., Wang, C., Yang, L., Li, Y. and Zhou, Z. (2018) Short-Course Radiotherapy with Immedi-ate or Delayed Surgery in Rectal Cancer: A Meta-Analysis. International Journal of Surgery, 56, 195-202.
https://doi.org/10.1016/j.ijsu.2018.05.031
|
[37]
|
Lefèvre, J.H., Mineur, L., Cachanado, M., Denost, Q., Rouanet, P., de Chaisemartin, C., Meunier, B., Mehrdad, J., Cotte, E., Desrame, J., Karoui, M., Benoist, S., Kirzin, S., Berger, A., Panis, Y., Piessen, G., Saudemont, A., Prudhomme, M., Peschaud, F., Dubois, A., Loriau, J., Tuech, J.-J., Meurette, G., Lupinacci, R., Goasguen, N., Creavin, B., Simon, T. and Parc, Y. (2019) Does a Longer Waiting Period after Neoadju-vant Radio-Chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years’ Follow-Up Results of the Greccar-6 Randomized Multicenter Trial. Annals of Surgery, 270, 747-754. https://doi.org/10.1097/SLA.0000000000003530
|
[38]
|
Gwynne, S. and Staffurth, J. (2012) Principles of Cancer Treatment by Radiotherapy. Surgery, 30, 191-193.
https://doi.org/10.1016/j.mpsur.2012.01.012
|
[39]
|
Erlandsson, J., Holm, T., Pettersson, D., Berglund, Å., Cedermark, B., Radu, C., Johansson, H., Machado, M., Hjern, F., Hallböök, O., Syk, I., Glimelius, B. and Martling, A. (2017) Optimal Fractionation of Preoperative Radiotherapy and Timing to Surgery for Rectal Cancer (Stockholm III): A Multicentre, Randomised, Non-Blinded, Phase 3, Non-Inferiority Trial. The Lancet Oncology, 18, 336-346. https://doi.org/10.1016/S1470-2045(17)30086-4
|
[40]
|
Baglan, K.L., Frazier, R.C., Yan, D., Huang, R.R., Martinez, A.A. and Robertson, J.M. (2002) The Dose-Volume Realationship of Acute Small Bowel Toxicity from Concurrent 5-FU-Based Chemotherapy and Radiation Therapy for Rectal Cancer. International Journal of Radiation Oncology, Bi-ology, Physics, 52, 176-183.
https://doi.org/10.1016/S0360-3016(01)01820-X
|
[41]
|
Tho, L.M., Glegg, M., Paterson, J., Yap, C., MacLeod, A., McCabe, M. and McDonald, A.C. (2006) Acute Small Bowel Toxicity and Preoperative Chemoradiotherapy for Rectal Cancer: Investigating Dose-Volume Relationships and Role for Inverse Planning. International Journal of Radiation Oncology, Biology, Physics, 66, 505-513.
https://doi.org/10.1016/j.ijrobp.2006.05.005
|
[42]
|
Robertson, J.M., Lockman, D., Yan, D. and Wallace, M. (2008) The Dose-Volume Relationship of Small Bowel Irradiation and Acute Grade 3 Diarrhea during Chemoradiotherapy for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics, 70, 413-418. https://doi.org/10.1016/j.ijrobp.2007.06.066
|
[43]
|
Wolff, H.A., Wagner, D.M., Conradi, L.C., Hennies, S., Ghadimi, M., Hess, C.F. and Christiansen, H. (2012) Irradiation with Protons for the Individualized Treatment of Patients with Locally Advanced Rectal Cancer: A Planning Study with Clinical Implications. Radiotherapy and Oncology, 102, 30-37. https://doi.org/10.1016/j.radonc.2011.10.018
|
[44]
|
Polico, C., Capirci, C., Stevanin, C., et al. (1993) Enteropatia da Raggi. Scientifiche Nutricia, Milano, 1-44.
|
[45]
|
Harling, H. and Balslev, I. (1988) Long-Term Prognosis of Patients with Severe Radiation Enteritis. The American Journal of Surgery, 155, 517-519. https://doi.org/10.1016/S0002-9610(88)80126-0
|
[46]
|
Pointreau, Y., Atean, I. and Durdux, C. (2010) Dose de tolérance à l’irradiation des tissus sains: La vessie [Normal Tissue Tolerance to External Beam Radiation Therapy: Bladder]. Cancer/Radiothérapie, 14, 363-368. (In French)
https://doi.org/10.1016/j.canrad.2010.02.007
|
[47]
|
Li, Y., Wang, J., Ma, X., Tan, L., Yan, Y., Xue, C., et al. (2016) A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. International Journal of Biological Sciences, 12, 1022-1031.
https://doi.org/10.7150/ijbs.15438
|
[48]
|
Buchli, C., Martling, A., Arver, S. and Holm, T. (2011) Testicular Function after Radiotherapy for Rectal Cancer—A Review. The Journal of Sexual Medicine, 8, 3220-3226. https://doi.org/10.1111/j.1743-6109.2011.02455.x
|
[49]
|
De Felice, F., Marchetti, C., Marampon, F., Cascialli, G., Muzii, L. and Tombolini, V. (2019) Radiation Effects on Male Fertility. Andrology, 7, 2-7. https://doi.org/10.1111/andr.12562
|
[50]
|
World Health Organization (2010) WHO Laboratory Manual for the Ex-amination and Processing of Human Semen. 5th Edition, World Health Organization, Geneva. https://fctc.who.int/publications/i/item/9789241547789
|
[51]
|
Hennies, S., Wolff, H., Jung, K., Rave-Fränk, M., Gaedcke, J., Ghadimi, M., et al. (2012) Testicular Radiation Dose after Multimodal Curative Therapy for Locally Ad-vanced Rectal Cancer. Influence on Hormone Levels, Quality of Life, and Sexual Functioning. Strahlentherapie und Onkologie, 188, 926-932.
https://doi.org/10.1007/s00066-012-0139-7
|
[52]
|
de la Motte, L., Custovic, S., Tapper, J., Arver, S., Martling, A. and Buchli, C. (2021) Effect of Preoperative Radiotherapy for Rectal Cancer on Spermatogenesis. British Journal of Surgery, 108, 750-753.
https://doi.org/10.1093/bjs/znab019
|
[53]
|
Eade, T.N., Hanlon, A.L., Horwitz, E.M., Buyyounouski, M.K., Hanks, G.E. and Pollack, A. (2007) What Dose of External-Beam Radiation Is High Enough for Prostate Cancer? International Journal of Radiation Oncology, Biology, Physics, 68, 682-689. https://doi.org/10.1016/j.ijrobp.2007.01.008
|
[54]
|
Viani, G.A., Stefano, E.J. and Afonso, S.L. (2009) High-er-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-Analysis of Randomized, Con-trolled Trials. International Journal of Radiation Oncology, Biology, Physics, 74, 1405-1418. https://doi.org/10.1016/j.ijrobp.2008.10.091
|
[55]
|
Mellon, E.A., Javedan, K., Strom, T.J., Moros, E.G., Biagioli, M.C., Fernandez, D.C., et al. (2015) A Dosimetric Comparison of Volumetric Modulated Arc Therapy with Step-and-Shoot Intensity Modulated Radiation Therapy for Prostate Cancer. Practical Radiation Oncology, 5, 11-15. https://doi.org/10.1016/j.prro.2014.03.003
|
[56]
|
Dröge, L.H., Weber, H.E., Guhlich, M., Leu, M., Conradi, L.C., Gaedcke, J., et al. (2015) Reduced Toxicity in the Treatment of Locally Advanced Rectal Cancer: A Comparison of Volumetric Modulated Arc Therapy and 3D Conformal Radiotherapy. BMC Cancer, 15, Article No. 750. https://doi.org/10.1186/s12885-015-1812-x
|
[57]
|
Zhao, J., Hu, W., Cai, G., Wang, J., Xie, J., Peng, J., et al. (2016) Dosimetric Comparisons of VMAT, IMRT and 3DCRT for Locally Advanced Rectal Cancer with Simultaneous Inte-grated Boost. Oncotarget, 7, 6345-6351.
https://doi.org/10.18632/oncotarget.6401
|
[58]
|
Shi, J., Yang, F., Ju, X., Huang, Y. and Jiang, F. (2017) Compara-tive Study on Dosimetry of VMAT and IMRT in Assisted Radiotherapy after Radical Resection of Rectal Cancer. On-cology Letters, 13, 2971-2974.
https://doi.org/10.3892/ol.2017.5842
|
[59]
|
Duman, E., Bilek, Y. and Ceyran, G. (2021) A Comparison of Radio-therapy Treatment Planning Techniques in Patients with Rectal Cancers by Analyzing Testes Doses. Journal of Cancer Research and Therapeutics, 17, 56-61.
https://doi.org/10.4103/jcrt.JCRT_328_19
|